Next Article in Journal
Real-Life Advantages and Limits of Baricitinib for the Late Treatment of Adults Hospitalized with COVID-19
Previous Article in Journal
A Longitudinal Assessment of Substance Use Treatment during the COVID-19 Pandemic Using Staff and Service Data
 
 
Article

Article Versions Notes

BioMed 2023, 3(2), 225-235; https://doi.org/10.3390/biomed3020020
Action Date Notes Link
article pdf uploaded. 10 April 2023 15:39 CEST Version of Record https://www.mdpi.com/2673-8430/3/2/20/pdf-vor
article xml uploaded. 11 April 2023 04:04 CEST Original file https://www.mdpi.com/2673-8430/3/2/20/xml
article pdf uploaded. 11 April 2023 04:04 CEST Updated version of record https://www.mdpi.com/2673-8430/3/2/20/pdf
article html file updated 11 April 2023 04:05 CEST Original file -
article html file updated 20 April 2023 21:32 CEST Update https://www.mdpi.com/2673-8430/3/2/20/html
Back to TopTop